Casgevy
Payments companies reported to CMS as associated with Casgevy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Casgevy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Casgevy
These are the largest totals companies reported as associated with Casgevy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Labelle | Chicago, IL | Pediatric Hematology-Oncology | $26,619.54 |
| Sonali Chaudhury | Chicago, IL | Pediatric Hematology-Oncology | $11,046.71 |
| David Jacobsohn | Chicago, IL | Pediatric Hematology-Oncology | $9,834.93 |
| Michael Grimley | Cincinnati, OH | Pediatric Hematology-Oncology | $9,408.28 |
| Akshay Sharma | Memphis, TN | Pediatric Hematology-Oncology | $9,359.69 |
| Leslie Lehmann | Boston, MA | Pediatric Hematology-Oncology | $8,317.50 |
| Erin Goodhue | Columbus, OH | Anatomic Pathology & Clinical Pathology | $7,800.00 |
| Venee Tubman | Houston, TX | Pediatric Hematology-Oncology | $7,500.00 |
| Elizabeth Stenger | Pittsburgh, PA | Pediatric Hematology-Oncology | $7,293.05 |
| Hemalatha Rangarajan | Columbus, OH | Pediatric Hematology-Oncology | $7,228.29 |
Prescribed Casgevy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.